Abstract Body

Background

Despite effective antiretroviral therapy, HIV-1 persistence in latent reservoirs of T-lymphoid and myeloid origins remains a major obstacle to a cure. The molecular mechanisms of HIV-1 latency are complex and multifactorial involving numerous blocks to viral gene expression, including transcriptional and epigenetic blocks. Deciphering the underlying mechanisms that drive HIV-1 into latency is critical for targeted HIV cure efforts.

Methods

Electrophoretic mobility shift Assays (EMSAs), chromatin immunoprecipitation (ChIP)-qPCR, RNA interference, mass spectrometry, infections. 

Results

In order to identify new cellular factors regulating transcription from the HIV-1 5’LTR promoter, we conducted a screen using a DNA-affinity capture method combined with an improved mass spectrometry process with a 100 bp probe centered on the U3 core promoter of the 5’LTR. Among the factors identified, we decided to study KLF16 (Krüppel-like Factor 16) not previously known to affect HIV-1 transcription and we demonstrated that KLF16 physically and functionally competed with Sp1 for binding to the three Sp1 sites located in the HIV core promoter. Overexpression of KLF16 caused a decrease in luciferase activity in LTR-driven reporter gene assays using both T-lymphocytic and monocytic cell lines. Moreover, knockdown of KLF16 reactivated HIV-1 transcription and replication in both T-lymphoid and myeloid HIV-1 latently-infected cell lines. Mechanistically, KLF16 downregulation induced a decreased in vivo recruitment of the chromatin-modifying enzyme complexes mSin3A/HDAC1 and HP1alpha/Suv39H1, as shown by ChIP-qPCR. This was accompanied by increased acetylation and decreased methylation of histones, as observed by in vivo enrichments for the activating epigenetic marks H3K9ac and H3K27ac and for the repressive epigenetic mark H3K9me3, respectively. Importantly, CD4+ T cells exposed to single-round VSV-G-pseudotyped HIV-1 produced increased p24 levels following siRNA-mediated KLF16 downregulation, thereby supporting that KLF16 contributes to HIV-1 silencing.

Conclusions

Taken together, our results report for the first time the role of the cellular transcription factor KLF16 in HIV-1 transcriptional silencing and identify this factor as a novel potential therapeutic target